Sponsor Pipeline

NewAmsterdam Pharma Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
3
Recruiting
3
Phase 3
4
Disease Areas
Active Trials by Phase
Phase 3
3
Phase 2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07219602 A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or… Lipidemia Recruiting
NCT05202509 Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With… Atherosclerotic Cardiovascular Disease Active, Not Recruiting
NCT06305559 A CCTA Imaging Trial to Evaluate the Effect of Obicetrapib/Ezetimibe on Coronary Plaque Lipidemia Active, Not Recruiting
Phase 2
NCT06982508 Evaluation of Obicetrapib on Antioxidant Levels in Plasma and HDL Particles of Healthy… Antioxidant Absorption Recruiting
NCT06496243 Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) Levels Dyslipidemias Recruiting
Phase 1
NCT05972278 Investigating the Effect of Obicetrapib on Lipoprotein Metabolism Lipid Metabolism Active, Not Recruiting
Disease Areas
Heart Disease (1) Coronary Artery Disease (1) Type 2 Diabetes (1) Diabetes (1)
Get alerts when NewAmsterdam Pharma's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free